PCG
UTHR icon

Prosperity Consulting Group’s United Therapeutics UTHR Stock Holding History

Prosperity Consulting Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,926
Closed -$1.23M – 529
2025
Q3 		$1.23M Hold
2,926
– – 0.06% 217
2025
Q2 		$841K Hold
2,926
– – 0.06% 253
2025
Q1 		$902K Hold
2,926
– – 0.07% 237
2024
Q4 		$1.03M Buy
+2,926
New +$1.08M 0.08% 220

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Prosperity Consulting Group's UTHR Position: Q4 2025 in Review

Prosperity Consulting Group sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 2,926 shares — an estimated $1.23M sold.

Prosperity Consulting Group first reported a position in UTHR in Q4 2024 and held it in 4 quarters. The position peaked at $1.23M in Q3 2025. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • Prosperity Consulting Group reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Prosperity Consulting Group sold 2,926 United Therapeutics shares in Q4 2025, an estimated $1.23M.
  • Prosperity Consulting Group first reported a position in United Therapeutics in Q4 2024 and held it in 4 quarters.
  • Prosperity Consulting Group's United Therapeutics position peaked at $1.23M in Q3 2025.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Prosperity Consulting Group's 13F filing for Q4 2025, filed 17 Feb 2026.